Precipio, Inc.
PRPO Nasdaq Laboratory Analytical Instruments Financials FY2016βFY2025
What Precipio, Inc. does
No business description yet.
- Legal name
- Precipio, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 30, 2026
- Accession Β· CIK
- 0001104659-26-036878
0001043961
Revenue and margins
Precipio, Inc. had $24.0M of revenue in fiscal 2025, up 29.8% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $0.4M in fiscal 2025, 1.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Precipio, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 9.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably Precipio, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $11.7M | $3.4M | $1.5M | $1.4M | $2.7M |
| Debt incl. finance leases | $0.6M | $0.6M | $0.5M | $0.9M | $1.0M |
| Net debt / EBITDA | β | β | β | β | β37.4x |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Current ratio | 3.2x | 1.3x | 1.2x | 0.8x | 1.6x |
| Quick ratio | 3.1x | 1.1x | 1.1x | 0.6x | 1.4x |
| Total assets | $30.4M | $21.5M | $18.1M | $17.0M | $21.3M |
| Total liabilities | $5.8M | $5.1M | $3.7M | $4.9M | $6.8M |
| Shareholders' equity | $24.6M | $16.3M | $14.4M | $12.1M | $14.6M |
| Net debt (β = net cash) | β$11.1M | β$2.8M | β$1.0M | β$0.5M | β$1.6M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 9 | 5 / 9 | 4 / 9 | 5 / 9 | 5 / 9 | 3 / 9 | 4 / 9 | 5 / 9 | 7 / 9 |
| Accruals ratio | β150.6% | β99.7% | β36.6% | β20.0% | β15.7% | β7.6% | β17.2% | β11.6% | β26.9% | β5.5% |
| Altman Z'' | β75.76 | β8.63 | β14.74 | β12.60 | β12.11 | β4.28 | β14.25 | β16.18 | β19.04 | β13.13 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.7M | $1.7M | $2.9M | $3.1M | $6.1M | $8.8M | $9.4M | $15.2M | $18.5M | $24.0M |
| Gross profit | $0.8M | $0.3M | $0.2M | $0.2M | $1.2M | $2.4M | $2.5M | $6.0M | $7.6M | $10.7M |
| Research and development | $0.0M | $0.5M | $1.1M | $1.2M | $1.2M | $1.3M | $1.7M | $1.7M | $1.3M | $1.6M |
| Operating income | β$1.7M | β$15.5M | β$13.9M | β$11.0M | β$9.1M | β$9.6M | β$12.8M | β$7.6M | β$4.2M | β$1.2M |
| Pretax income | β$2.2M | β$20.7M | β$16.0M | β$13.3M | β$10.6M | β$8.5M | β$12.2M | β$5.9M | β$4.3M | β$0.4M |
| Income tax | $0.0M | $0.3M | β$0.3M | β$0.1M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net income | β$2.2M | β$20.7M | β$15.7M | β$13.2M | β$10.6M | β$8.5M | β$12.2M | β$5.9M | β$4.3M | β$0.4M |
| Net income to common | β$4.1M | β$33.2M | β$19.9M | β$13.2M | β$14.0M | β$8.5M | β$12.2M | β$5.9M | β | β |
| Diluted EPS | β$9.44 | β$7.16 | β$13.82 | β$2.33 | β$0.85 | β$0.40 | β$10.73 | β$4.51 | β$2.93 | β$0.23 |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.01B | 0.02B | 0.02B | 0.00B | 0.00B | 0.00B | 0.00B |
| Cash flow | ||||||||||
| Cash from operations | β$1.0M | β$6.7M | β$6.8M | β$9.1M | β$7.4M | β$6.6M | β$7.7M | β$3.6M | $0.4M | $0.7M |
| Capital expenditure | $0.0M | $0.1M | $0.1M | $0.1M | $0.2M | $0.7M | $0.3M | $0.1M | $0.2M | $0.3M |
| Free cash flow | β$1.0M | β$6.8M | β$6.9M | β$9.2M | β$7.6M | β$7.3M | β$8.0M | β$3.7M | $0.2M | $0.4M |
| Depreciation and amortization | $0.1M | $0.7M | $1.3M | $1.1M | $1.1M | $1.1M | $1.2M | $1.2M | $1.2M | $1.2M |
| Stock-based compensation | $0.0M | $0.0M | $0.5M | $0.7M | $0.7M | $1.9M | $3.8M | $1.6M | $1.5M | $1.2M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $0.1M | $0.4M | $0.4M | $0.8M | $2.7M | $11.7M | $3.4M | $1.5M | $1.4M | $2.7M |
| Total debt | $4.5M | $3.4M | $0.5M | $0.5M | $1.0M | $0.2M | $0.4M | $0.4M | $0.4M | $0.1M |
| Finance lease liabilities | β | β | β | $0.2M | $0.2M | $0.4M | $0.2M | $0.2M | $0.5M | $1.0M |
| Current assets | $0.6M | $1.7M | $1.8M | $1.9M | $4.2M | $13.5M | $5.7M | $3.7M | $3.5M | $6.0M |
| Current liabilities | $3.0M | $10.0M | $13.8M | $4.3M | $4.7M | $4.2M | $4.4M | $3.1M | $4.3M | $3.8M |
| Inventory | $0.1M | $0.2M | $0.2M | $0.2M | $0.4M | $0.6M | $0.7M | $0.4M | $0.7M | $0.9M |
| Property and equipment, net | $0.3M | $0.4M | $0.5M | $0.4M | $0.3M | $0.8M | $0.9M | $0.7M | $0.7M | $0.7M |
| Goodwill | β | $4.7M | β | β | β | β | β | β | β | β |
| Intangible assets | $0.0M | $20.5M | $19.3M | $16.7M | $15.7M | $14.7M | $13.8M | $12.8M | $11.9M | $10.9M |
| Total assets | $0.8M | $27.3M | $21.6M | $19.5M | $20.7M | $30.4M | $21.5M | $18.1M | $17.0M | $21.3M |
| Total liabilities | $7.3M | $14.2M | $15.5M | $6.3M | $6.6M | $5.8M | $5.1M | $3.7M | $4.9M | $6.8M |
| Preferred stock | $0.0M | β | β | β | β | β | β | β | β | β |
| Shareholders' equity | β$6.5M | $13.0M | $6.1M | $13.2M | $14.1M | $24.6M | $16.3M | $14.4M | $12.1M | $14.6M |
| Margins | ||||||||||
| Gross margin | 43.7% | 16.9% | 7.9% | 7.0% | 18.9% | 27.0% | 26.7% | 39.6% | 40.8% | 44.5% |
| Operating margin | β99.4% | β900.2% | β485.8% | β351.6% | β150.1% | β108.6% | β136.0% | β50.1% | β22.7% | β5.0% |
| EBITDA margin | β92.9% | β857.1% | β441.6% | β315.8% | β132.2% | β95.9% | β123.0% | β42.1% | β16.3% | 0.2% |
| Net margin | β129.3% | β1,201.0% | β548.0% | β423.5% | β174.0% | β96.2% | β129.4% | β38.5% | β23.1% | β1.5% |
| FCF margin | β56.8% | β396.6% | β239.2% | β294.1% | β124.5% | β82.0% | β85.0% | β24.2% | 1.2% | 1.5% |
| Returns | ||||||||||
| Return on capital | β | β76.5% | β175.6% | β67.3% | β57.8% | β58.1% | β76.2% | β45.3% | β30.0% | β7.9% |
| Return on capital employed | 78.9% | β90.1% | β177.4% | β72.4% | β57.0% | β36.7% | β74.6% | β50.9% | β33.1% | β6.8% |
| Return on equity | β | β630.4% | β163.9% | β137.0% | β77.5% | β44.0% | β59.6% | β38.1% | β32.3% | β2.7% |
| Return on assets | β264.5% | β147.3% | β64.2% | β64.4% | β52.7% | β33.3% | β46.9% | β29.6% | β24.4% | β1.9% |
| Return on tangible equity | β | β | β | β | β | β86.6% | β481.6% | β363.3% | β1,906.7% | β10.0% |
| Growth | ||||||||||
| Revenue growth | β | 0.0% | 66.2% | 9.2% | 94.8% | 45.3% | 6.4% | 61.5% | 21.9% | 29.8% |
| FCF growth | β | β | β | β | β | β | β | β | β | 66.2% |
| Share count change | β | 972.4% | β68.9% | 295.2% | 189.3% | 28.0% | β94.6% | 14.1% | 12.9% | 9.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β | β | β | β | β | β | β37.4x |
| Debt / equity | β | 0.3x | 0.1x | 0.0x | 0.1x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Current ratio | 0.2x | 0.2x | 0.1x | 0.4x | 0.9x | 3.2x | 1.3x | 1.2x | 0.8x | 1.6x |
| Quick ratio | 0.2x | 0.2x | 0.1x | 0.4x | 0.8x | 3.1x | 1.1x | 1.1x | 0.6x | 1.4x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.1% | 8.3% | 3.4% | 1.8% | 2.5% | 7.7% | 2.9% | 0.8% | 1.2% | 1.4% |
| Stock comp / revenue | 0.7% | 2.8% | 18.5% | 21.4% | 11.5% | 21.2% | 40.4% | 10.3% | 8.0% | 5.0% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 3.0 | 5.0 | 4.0 | 5.0 | 5.0 | 3.0 | 4.0 | 5.0 | 7.0 |
| Altman Z'' | β75.8 | β8.6 | β14.7 | β12.6 | β12.1 | β4.3 | β14.2 | β16.2 | β19.0 | β13.1 |
| Accruals ratio | β150.6% | β99.7% | β36.6% | β20.0% | β15.7% | β7.6% | β17.2% | β11.6% | β26.9% | β5.5% |
Source: SEC EDGAR XBRL filings (CIK 0001043961). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.